Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 7, 2023
Reporting Period: This filing is a current report regarding specific events on the date of filing, not a periodic financial report covering a fiscal quarter or year.
Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing serves solely to disclose upcoming investor communications and attach an investor presentation.
Material Changes
No material changes to financial results or operations are reported in this document. The filing discloses that executive officers have scheduled upcoming presentations to investors and analysts.
Guidance, Outlook, and Management Commentary
- Investor Presentations: Management intends to use the material in Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated August 2023) for upcoming meetings with investors and analysts.
- Regulation FD Disclosure: The information provided, including the attached presentation, is furnished under Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly referenced in another filing.
- Outlook: Specific forward-looking guidance or outlook details are not contained within the text of this 8-K; they are referenced as being contained in the attached Exhibit 99.1.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor Presentation dated August 2023) for actual financial data, strategic updates, and guidance, as this 8-K only references the document.
- Confirm the schedule of upcoming investor and analyst presentations mentioned by management.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act, limiting liability for forward-looking statements contained in the referenced presentation.